Skip to main content

Table 1 Clinical characteristics of the study participants

From: Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia

  Control PE P-value
N 20 17  
Age (years) 32.8 ± 5.3 30.2 ± 6.7 0.25
Pre-pregnancy BMI (kg/m2) 24.9 ± 4.9 25.2 ± 5.5 0.87
Gravidity (median, IQR) 2.5 (2–4) 2 (1–4) ND
Parity (median, IQR) 1 (1–2) 0 (0–1) ND
Ethniticy (Caucasian/other) 18/2 17/0 ND
SBP (T3) mmHg 118 ± 13 135 ± 18* 0.003
DBP (T3) mmHg 73 ± 9 84 ± 15* 0.01
SBP (early preg) mmHg 107 ± 8 115 ± 14 0.08
DBP (early preg) mmHg 65 ± 8 67 ± 10 0.40
Mode of delivery (VD/CS) 0/20 10/7 <0.0001
GA delivery (d) 269.6 ± 8.3 268.1 ± 10.3 0.64
Birth weight (g) 3279 ± 623 3150 ± 673 0.55
Baby gender (M/F) 10/10 9/8 ND
Glucose screen result (mmol/L) 5.76 ± 1.02 6.10 ± 1.46 0.51
  1. Results expressed as mean ± SD unless indicated otherwise; ND, not determined; VD, vaginal delivery; CS, Caesarean section; *11 of the 17 treated with anti-hypertensive agents.